Completed PHASE3 INTERVENTIONAL 2-arm NCT00116207

An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes

Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial

Sponsor: Juvenile Diabetes Research Foundation

Conditions Diabetic Autonomic Neuropathy

Updated 8 times since 2017 Last updated: Jun 30, 2016 Started: Jan 31, 2000 Primary completion: Sep 30, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00116207, this PHASE3 trial focuses on Diabetic Autonomic Neuropathy and remains completed. Sponsored by Juvenile Diabetes Research Foundation, it has been updated 8 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3
Jan 2021 — Dec 2022 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Juvenile Diabetes Research Foundation
University of Michigan

Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ann Arbor, United States